Term: Beta-Blocker

Printer friendly

Glossary Definition

Last Updated: 2014-10-14

Definition:

Also known as beta-adrenergic blocking agents, these drugs are used to reduce blood pressure and have been shown to lower the risk of subsequent heart attacks. These are identified by the Anatomical Therapeutic Chemical (ATC) drug classification codes: C07AA and C07AB.

For more information, see:

• Post-Acute Myocardial Infarction (AMI) Care: Beta-Blocker Prescribing glossary term.
  
• Information on beta-blockers on the Heart & Stroke Foundation Web Site at: http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3484113/k.7B27/Heart_disease__Betablockers.htm

Related concepts 

• Acute Myocardial Infarction (AMI) / Myocardial Infarction (MI) - Definition, Rates and Post-AMI Management

Related terms 

• Anatomical Therapeutic Chemical (ATC) Drug Classification System
• Post-Acute Myocardial Infarction (AMI) Care: Beta-Blocker Prescribing

References 

• Katz A, Chateau D, Bogdanovic B, Taylor C, McGowan K-L, Rajotte L, Dziadek J. Physician Integrated Network: A Second Look. Winnipeg, MB: Manitoba Centre for Health Policy, 2014. [Report] [Summary] [Updates and Errata] (View)

Term used in 

• Chartier M, Finlayson G, Prior H, McGowan K, Chen H, de Rocquigny J, Walld R, Gousseau M. Health and Healthcare Utilization of Francophones in Manitoba. Winnipeg, MB: Manitoba Centre for Health Policy, 2012. [Report] [Summary] (View)
• Katz A, Bogdanovic B, Soodeen R. Physician Integrated Network Baseline Evaluation: Linking Electronic Medical Records and Administrative Data. Winnipeg, MB: Manitoba Centre for Health Policy, 2010. [Report] [Summary] (View)
• Katz A, De Coster C, Bogdanovic B, Soodeen R, Chateau D. Using Administrative Data to Develop Indicators of Quality in Family Practice. Winnipeg, MB: Manitoba Centre for Health Policy, 2004. [Report] [Summary] (View)
• Martens P, Brownell M, Au W, MacWiliam L, Prior H, Schultz J, Guenette W, Elliott L, Buchan S, Anderson M, Caetano P, Metge C, Santos R, Serwonka K. Health Inequities in Manitoba: Is the Socioeconomic Gap in Health Widening or Narrowing Over Time? Winnipeg, MB: Manitoba Centre for Health Policy, 2010. [Report] [Summary] [Updates and Errata] [Additional Materials] (View)
• Martens PJ, Bartlett J, Burland E, Prior H, Burchill C, Huq S, Romphf L, Sanguins J, Carter S, Bailly A. Profile of Metis Health Status and Healthcare Utilization in Manitoba: A Population-Based Study. Winnipeg, MB: Manitoba Centre for Health Policy, 2010. [Report] [Summary] [Updates and Errata] [Additional Materials] (View)
• Metge C, Chateau D, Prior H, Soodeen R, De Coster C, Barre L. Composite Measures/Indices of Health and Health System Performance. Winnipeg, MB: Manitoba Centre for Health Policy, 2009. [Report] [Summary] (View)
• Morgan SG, Kozyrskyj A, Metge C, Roos NP. Pharmaceuticals: Therapeutic interchange and pricing policies. Winnipeg, MB: Manitoba Centre for Health Policy, 2003. [Report] [Summary] (View)